Harvard Bioscience Inc. (HBIO)

NASDAQ

$8.28

$+0.01

(+0.12%)

Previous Close: ⁦$8.34⁩

Market Closed

Harvard Bioscience Inc. (HBIO) Live Price Chart

Last updated: ⁦2026-10-24 07:43:40⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Harvard Bioscience Inc. (HBIO) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NASDAQ. The stock is currently priced at $8.28, with a market capitalization of $37.97M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.95 to $9.40. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$37.97M
Open	$8.13
Day's High	$111.00
Day's Low	$2.81
Previous Close	$8.34
Volume	26.25K
Average Volume	18.51K
P/E Ratio	--
52-Week High	$9.40
52-Week Low	$3.95
Dividend Yield	--
Earnings Date	--

Harvard Bioscience Inc. (HBIO) Latest Closing Stock Price

Harvard Bioscience Inc. (HBIO) last closed at $8.34 as of 2026-10-23 23:31:00, unchanged from the previous close of $8.34.

During the latest regular trading session, HBIO traded between $2.81 and $111.00, with a volume of 26.25K shares. The closing price was near the lower end and near the upper end of its 52-week range.

Harvard Bioscience Inc. (HBIO) 7-Day Stock Price Change

Over the past seven days, Harvard Bioscience Inc. (HBIO) moved from $8.31 to $8.28, representing a decline of 0.36% ($0.03).

The stock traded between $7.90 and $8.49 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.

The average daily volume was 16.52 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

HBIO 52-Week Price Position

Position in Range: 79.4%

52W Low$3.95

52W High$9.40

HBIO is currently trading at $8.28, placing it 79.4% of the way from its 52-week low of $3.95 to its 52-week high of $9.40. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Harvard Bioscience Inc. (HBIO)?

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

Harvard Bioscience Inc. Information

Industry	LABORATORY ANALYTICAL INSTRUMENTS
Employees	339
Exchange	NASDAQ
Company Website	https://www.harvardbioscience.com

How to Buy Harvard Bioscience Inc. (HBIO) Stock on MEXC

Eligible investors can buy real shares of Harvard Bioscience Inc. (HBIO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for HBIO and Place Your Order

Open the RealStocks trading page and search for HBIO. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Harvard Bioscience Inc. (HBIO) stock price today?

Harvard Bioscience Inc. (HBIO) is currently trading at $ 8.28, down 0.72% ($0.06) from the previous close of $ 8.34. Intraday prices update in real time during regular trading hours.

2.Is HBIO stock going up or down today?

As of 2026-10-23 23:31:00, HBIO is trading at $ 8.28, down 0.72% ($0.06) from its previous close of $ 8.34. The stock has traded between $ 2.81 and $ 111.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is HBIO pre-market price?

As of 2026-10-23 23:31:00, HBIO is trading at $ 8.30 in pre-market trading, down 0.48% ($0.04) from the previous close of $ 8.34. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is HBIO after-hours price?

As of 2026-10-23 23:31:00, HBIO is trading at $ 8.21 in after-hours trading, down 1.56% ($0.13) from the regular-session close of $ 8.34. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is HBIO stock trading now?

HBIO trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does HBIO sit relative to its 52-week high and low?

Over the past 52 weeks, HBIO has traded between a low of $ 3.95 and a high of $ 9.40. At $ 8.28, the stock is positioned 79.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Harvard Bioscience Inc. in?

Harvard Bioscience Inc. (HBIO) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Harvard Bioscience Inc.'s market capitalization and where is it listed?

Harvard Bioscience Inc. is listed on the NASDAQ exchange with a market capitalization of $ 37.97M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is HBIO valued in terms of P/E ratio and EPS?

HBIO trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2.29. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Harvard Bioscience Inc. pay a dividend?

Harvard Bioscience Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.